Edwards Lifesciences Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$1,569,600	$1,553,100	$1,532,200	$1,412,700
Gross Profit	1,229,000	1,209,600	1,189,600	1,111,100
EBITDA	90,400	387,600	400,200	470,500
EBIT		348,400	362,100	433,900
Net Income	91,200	291,100	329,800	358,000
Net Change In Cash	1,569,600	1,553,100	1,532,200	1,412,700
Free Cash Flow	353,500	516,200	240,900	224,400
Cash	2,938,000	2,685,600	3,272,800	3,140,600
Basic Shares	581,800	585,700	587,900	587,800

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$6,067,600	$5,439,500	$6,004,800	$5,382,400
Gross Profit	4,740,700	4,322,000	4,625,000	4,215,200
EBITDA	1,272,900	1,723,100	1,534,100	1,960,400
EBIT		1,567,900	1,534,100	1,793,600
Net Income	1,073,500	4,174,600	1,402,400	1,521,900
Net Change In Cash	6,067,600	5,439,500	6,004,800	5,382,400
Cost of Revenue				-114,000
Free Cash Flow	1,335,000	289,900	629,500	953,400
Cash	2,938,000	3,045,200	1,132,300	769,000
Basic Shares	585,800	599,300	609,400	624,200